Unlocking the Potential of iPSC Therapies for Parkinson’s Disease

Time: 9:00 am
day: Conference Day Two


  • Investigating the expanding application of iPSC technology to create cell-based therapies for Parkinson’s disease
  • Highlighting the importance of developing reliable preclinical models to assess the safety and effectiveness of iPSC therapies in Parkinson’s disease